MVP — Medical Developments International Cashflow Statement
0.000.00%
- AU$65.91m
- AU$50.06m
- AU$39.06m
- 73
- 51
- 71
- 75
Annual cashflow statement for Medical Developments International, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | C2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0.044 | 0.14 | 0.784 | 0.336 | 0.24 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -8.89 | -10.8 | -16.5 | -10.8 | -0.043 |
Capital Expenditures | -6.56 | -5.21 | -7.67 | -3.17 | -1.04 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.082 | 0.055 | — | — | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -6.48 | -5.16 | -7.67 | -3.17 | -1.04 |
Financing Cash Flow Items | -0.727 | -0.003 | -1.68 | -0.533 | -1.04 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 36.1 | 0.142 | 28.1 | -0.807 | 8.68 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 20.7 | -15.9 | 4.26 | -14.9 | 8.1 |